1 October 2015 in RadioGraphics
Considerations, safety issues, and potential adverse effects of ionizing radiation when imaging pregnant and lactating patients are explained to help radiologists adhere to the “as low as reasonably achievable” principle, minimize risk, and adequately address concerns of patients and referring physicians. As use of imaging in the evaluation of pregnant and lactating patients continues to increase, misperceptions of radiation and safety risks have proliferated, which has led to often unwarranted concerns among patients and clinicians. When radiologic examinations are appropriately used, the benefits derived from the information gained usually outweigh the risks. This review describes appropriateness and safety issues, estimated doses for imaging examinations that use iodizing radiation (ie, radiography, computed tomography, nuclear scintigraphy, and fluoroscopically guided interventional radiology), radiation risks to the mother and conceptus during various stages of pregnancy, and use of iodinated or gadolinium-based contrast agents and radiotracers in pregnant and lactating women. Maternal radiation risk must be weighed with the potential consequences of missing a life-threatening diagnosis such as pulmonary embolus. Fetal risks (ie, spontaneous abortion, teratogenesis, or carcinogenesis) vary with gestat...
1 November 2018 in RadioGraphics
This article reviews the prognostic considerations of breast cancer and includes patient factors and staging, imaging, histologic, and molecular findings; understanding these prognostic factors and their implications enables radiologists to contribute meaningfully to the multidisciplinary team and positively affect patient outcomes. An understanding of prognostic factors in breast cancer is imperative for guiding patient care. Increased tumor size and more advanced nodal status are established independent prognostic factors of poor outcomes and are incorporated into the American Joint Committee on Cancer (AJCC) TNM (primary tumor, regional lymph node, distant metastasis) staging system. However, other factors including imaging findings, histologic evaluation results, and molecular findings can have a direct effect on a patient’s prognosis, including risk of recurrence and relative survival. Several microarray panels for gene profiling of tumors are approved by the U.S. Food and Drug Administration and endorsed by the American Society of Clinical Oncology. This article highlights prognostic factors currently in use for individualizing and guiding breast cancer therapy and is divided into four sections. The first section addresses patient considerations, in which modifiable and nonmodifiable prognostic factors including age, race and e...
7 June 2019 in Journal of Digital Imaging
1 July 2020 in RadioGraphics
Identifying those patients who would benefit from genetic testing for hereditary breast cancer, understanding the various components of genetic counseling, and recognizing the gene mutations that p... Professionals who specialize in breast imaging may be the first to initiate the conversation about genetic counseling with patients who have a diagnosis of premenopausal breast cancer or a strong f...
27 June 2016 in Abdominal Radiology